abstract |
The invention relates to the use of at least one compound of general formula (I) and/or one of its diastereomers and/or one of its enantiomers and/or one of the corresponding physiologically compatible salts for producing a medicament for combating respiratory depression, with the exception of medicaments for combating respiratory depression as a cause of sleep apnea. |